We created an in vitro model to understand the disparate mechanisms whereby this KATP channel variation causes hyperinsulinaemia in utero and in infancy yet increases risk of type 2 diabetes, a disease characterised by impaired insulin secretion, later in life. The gene discussed is INS; the disease is type 2 diabetes mellitus.